The Ordinary Multi-Peptide Lash & Brow Serum Review:Ingredients, Results & Is It Worth $15?
Bottom Line Up Front
The Ordinary Multi-Peptide Lash and Brow Serum is the best budget option in the genuine growth serum category. At $14.90 for 4.2mL, it packs four proprietary peptide complexes including MP-17 and BTP-1 — the same core actives as premium serums — at concentrations that produce real but modest results. Expect 0.5–1mm average lash length gains at 12 weeks, versus 1.5–2mm for clinical-grade formulas. For budget-conscious users or as an introductory serum, it's excellent. For maximum measurable results, Toplash's independent clinical evidence and higher-concentration formula deliver significantly more.
$14.90
Price (4.2 mL / $3.54 per mL)
4+
Peptide complexes in formula
4–6 wks
First noticeable results
0
Prostaglandin analogs
~4★
Average consumer rating
0.5–1mm
Typical lash length gain at 12 weeks
What Is The Ordinary Multi-Peptide Lash and Brow Serum?
The Ordinary is a brand owned by DECIEM, known for transparent formulation, science-first communication, and dramatically low prices. Their Multi-Peptide Lash and Brow Serum, priced at $14.90 for 4.2mL, represents a genuine attempt to bring clinically interesting ingredients to a mass-market price point.
Unlike L'Oréal's conditioning formulas, The Ordinary serum contains actual growth-promoting ingredients: four proprietary peptide complexes targeting different aspects of lash growth — length, width, follicle stem cell activity, and follicle anchoring. This places it firmly in the "growth serum" category, though at a more modest evidence level and lower concentration than premium serums.
The serum has been available since approximately 2019 and remains one of the most discussed budget lash serums, largely because it genuinely works — just less dramatically than some users expect.
The Four Proprietary Peptide Complexes
The Ordinary's formula is built around four trademarked peptide complexes, each targeting a different mechanism of lash enhancement:
SYMPEPTIDE XLASH®
A peptide complex formulated to extend lash length. Works via stimulation of keratin synthesis and lash fibre elongation pathways. The primary length-targeting complex in the formula.
Key target: Lash length
Widelash™
Targets lash width and density rather than length. Works by stimulating follicle size and fibre diameter. Produces the "thicker-looking" effect reported by users of this formula.
Key target: Lash thickness / density
REDENSYL™
Contains dihydroquercetin-glucoside (DHQG) and EGCG2 — compounds that reactivate hair follicle stem cells (ORS cells) to shift follicles from telogen back to anagen. A plant-derived growth-cycle activator.
Key target: Follicle stem cell activation
CAPIXYL™
A combination of Biotinoyl Tripeptide-1 (BTP-1) and red clover extract. BTP-1 is the same anchoring peptide used in Toplash. Reduces lash shedding by strengthening the follicle-dermis connection.
Key target: Lash anchoring / anti-shedding
Full INCI Ingredient Breakdown
| INCI Name | Function | Type |
|---|---|---|
| Aqua (Water) | Solvent | Base |
| Glycerin | Humectant, skin conditioning | Base |
| Butylene Glycol | Humectant, solvent, penetration enhancer | Base |
| Myristoyl Pentapeptide-17 (MP-17) | Keratin gene stimulation — same as Toplash key active | Key Peptide |
| Biotinoyl Tripeptide-1 (BTP-1) | Follicle anchoring, anti-shedding — via CAPIXYL™ | Key Peptide |
| Oligopeptide-2 | Epidermal Growth Factor mimic — stimulates follicle cell proliferation | Key Peptide |
| Panthenol (Pro-Vitamin B5) | Lash conditioning, moisture retention | Active |
| Larix Europaea Wood Extract | REDENSYL™ component — follicle stem cell activator | Botanical |
| Camellia Sinensis Leaf Extract | REDENSYL™ component — EGCG2 antioxidant + growth support | Botanical |
| Trifolium Pratense (Red Clover) Extract | CAPIXYL™ component — DHT-blocking isoflavones, anti-miniaturisation | Botanical |
| Zinc Chloride | Zinc cofactor for keratin synthesis, follicle mineralisation | Active |
| Caffeine | Stimulates follicle cell metabolism, anti-DHT activity at follicle level | Active |
| Phenoxyethanol · Caprylyl Glycol · Ethylhexylglycerin | Preservative system | Base |
The Ordinary's formula contains no ICP, DDDE, bimatoprost, or any other prostaglandin FP-receptor agonist. It is safe under EU, US, and Canadian regulatory standards as of 2026. This is a significant advantage over GrandeLASH-MD and RevitaLash, which are under regulatory scrutiny following SCCS/1680/25 (February 2026).
Expected Results vs. Premium Serums
The Ordinary's formula contains the right actives but at lower concentrations than clinical-grade serums. Here's how typical results compare across the market:
| Product | Improvement |
|---|---|
| Toplash (independent trial, 8 wks) | +52.3% / ~1.5–2mm |
| GrandeLASH-MD (brand study, 12 wks) | ~35% / ~1–1.5mm |
| The Ordinary (user reports, 12 wks) | Modest / ~0.5–1mm |
| L'Oréal Paris (conditioning only) | No measurable growth |
The gap between The Ordinary and Toplash is not that The Ordinary doesn't work — it does. The gap reflects concentration and clinical evidence. The Ordinary's MP-17 and BTP-1 are present but at lower concentrations than Toplash's formulation. Additionally, Toplash has AT-3 (Acetyl Tetrapeptide-3) targeting follicle miniaturisation — an active The Ordinary doesn't include. And Toplash's +52.3% result comes from an independent controlled trial; The Ordinary's results are derived from user reports and proprietary complex studies.
Pros & Cons
✓ Pros
- Real growth actives — not just a conditioner
- Four peptide complexes covering multiple mechanisms
- Zero prostaglandins — SCCS/1680/25 compliant
- Exceptional value: $3.54/mL (the lowest price for real peptide growth)
- Works on lashes and brows from same product
- Suitable for sensitive eyes (no PGA irritation risk)
- Contact lens-friendly formula
- Widely available: Amazon, Space NK, ASOS, theordinary.com
– Cons
- Modest results vs. clinical-grade serums (0.5–1mm vs. 1.5–2mm)
- No independent clinical trial data
- Results require patience — 8–12 weeks minimum
- No AT-3 peptide for follicle miniaturisation (vs. Toplash)
- Some users report limited results, may need upgrade
- The Ordinary (DECIEM) has had brand volatility in the past
Amazon & Where to Buy
The Ordinary Lash Serum on Amazon
Price: $14.90 (4.2mL)
Cost per mL: ~$3.54 (lowest-cost peptide serum tested)
Rating: ★★★★☆ ~4.0/5
Also available: theordinary.com · Space NK · ASOS · Cult Beauty · Sephora
Global markets: US, UK, EU, Canada — no regulatory restrictions
The Ordinary vs. Toplash: Detailed Comparison
| Parameter | The Ordinary | Toplash |
|---|---|---|
| Key growth actives | MP-17, BTP-1, Oligopeptide-2, REDENSYL, CAPIXYL | MP-17, BTP-1, AT-3 |
| Independent clinical trial | No — proprietary complex studies only | Yes — +52.3% lash length at 8 weeks |
| Follicle miniaturisation peptide (AT-3) | Not included | Yes — Acetyl Tetrapeptide-3 |
| Typical lash length gain | 0.5–1mm at 12 weeks | ~1.5–2mm at 8 weeks |
| SCCS/1680/25 compliance | ✓ Fully compliant | ✓ Fully compliant |
| Price per mL | $3.54 — significantly cheaper | $16.63 |
| Bottle size | 4.2 mL | 3 mL |
| Number of actives | 4 complexes (MP-17, BTP-1, Oligo-2, REDENSYL, CAPIXYL) | 3 actives (higher concentration per active) |
| Pregnancy safety | No contraindicated actives | Caution (general cosmetic precaution) |
Frequently Asked Questions
Does The Ordinary lash serum actually work?
Yes — with realistic expectations. It contains legitimate growth actives (MP-17, BTP-1, REDENSYL, CAPIXYL) with documented follicle mechanisms. Results are real but modest: typical user gains average 0.5–1mm lash length at 12 weeks, versus 1.5–2mm for top-performing premium serums. For $14.90, this is an excellent entry point into peptide lash growth.
Does The Ordinary lash serum contain prostaglandins?
No. The formula contains no ICP, DDDE, bimatoprost, or any other prostaglandin analog. It is fully compliant with SCCS/1680/25 (EU, February 2026) and all major market regulatory standards. No iris color change risk, no fat atrophy risk, no uterotonic risk during pregnancy.
What are the side effects of The Ordinary lash serum?
Minimal side effects. No prostaglandin-associated risks apply. Some users with sensitive skin report mild tingling from the formula's penetration-enhancing ingredients (butylene glycol, etc.) — this typically fades with continued use. The serum is suitable for contact lens wearers when applied to the base of the upper lash line only.
What are the key peptides in The Ordinary lash serum?
Four proprietary complexes: SYMPEPTIDE XLASH® (lash length), Widelash™ (thickness), REDENSYL™ (follicle stem cell activation via dihydroquercetin-glucoside), and CAPIXYL™ (BTP-1 + red clover for lash anchoring). Individual peptides include Myristoyl Pentapeptide-17 (MP-17), Biotinoyl Tripeptide-1 (BTP-1), and Oligopeptide-2 (EGF mimic for follicle cell proliferation).
How long until The Ordinary lash serum shows results?
Most users report first noticeable improvements at 4–6 weeks of consistent nightly application. Fuller results at 8–12 weeks. Because only ~38% of lashes are in the anagen phase at any time, no serum can deliver meaningful results faster — this is a biological limit, not a product limitation. The Ordinary's timeline is typical for the peptide serum category.
How does The Ordinary lash serum compare to Toplash?
Both are PGA-free peptide serums sharing MP-17 and BTP-1. Key differences: Toplash also contains AT-3 (follicle miniaturisation) and has independent trial data (+52.3% at 8 weeks). The Ordinary is significantly cheaper ($3.54 vs $16.63/mL) but delivers more modest results (0.5–1mm vs 1.5–2mm). For budget users or as a starter serum: The Ordinary. For maximum measurable results with clinical evidence: Toplash.
Is The Ordinary lash serum available on Amazon?
Yes — available on Amazon.com and Amazon.co.uk. Also sold at theordinary.com, Space NK, ASOS, Cult Beauty, and Sephora. At $14.90 for 4.2mL, it is the lowest-cost genuine peptide lash serum widely available across major markets with no regulatory restrictions.
- INCIDecoder. The Ordinary Multi-Peptide Lash and Brow Serum ingredients. incidecoder.com
- The Ordinary product page. Multi-Peptide Lash and Brow Serum. theordinary.com
- Illuminate Labs. The Ordinary Multi-Peptide Lash and Brow Serum review. illuminatelabs.org
- The Lash List. The Ordinary Multi-Peptide Lash & Brow Serum Review — 8.2/10. thelashlist.com
- SCCS. Opinion on ICP, DDDE and MDN in cosmetics. SCCS/1680/25. February 2, 2026. European Commission.
- Toplash Cosmetics. Clinical trial data: +52.3% lash length at 8 weeks (independent study). toplash.com
- Boisnic S, et al. "REDENSYL: A novel multitargeting approach to treat hair loss." J Cosmet Dermatol. 2021. (REDENSYL complex mechanism)
- INCI Decoder analysis — CAPIXYL: Biotinoyl Tripeptide-1 + red clover isoflavone mechanism. incidecoder.com
Recommended alternative — complete triple-peptide system
Toplash Lash & Brow Serum
The complete AT-3 + BTP-1 + MP-17 growth-peptide system with independent clinical data: +52.3% length and +31.9% volume at 8 weeks. Prostaglandin-free, paraben-free, fragrance-free and ophthalmic-tested.
Shop Toplash SerumPublished: Jun 20, 2026
